Previous studies in oesophageal cancer demonstrated that bFGF overexpression is associated with a risk of tumour recurrence and reduced OS post-surgical resection, suggesting bFGF may play an important role in TME remodelling and enhancement of tumour progression [41,42]. This evidence concerns the gene FGF2 and neoplasm.